1887
Volume 2013, Issue 4
  • ISSN: 2305-7823
  • E-ISSN:

Abstract

The recent increase in human lifespan, coupled with unhealthy diets and lifestyles have led to an unprecedented increase in cardiovascular diseases. Even in the presence of a wide range of therapeutic options with variable efficacy, mortality due to heart failure is still high and there is a need to identify new therapeutic targets. Genetic and studies have implicated the Notch signalling in the development and maintenance of the cardiovascular system through a direct effect on biological functions of vascular cells (endothelial and vascular smooth muscle cells) and cardiomyocytes. Notch signalling is also involved in the modulation of inflammation, which plays a major role in causing and exacerbating cardiovascular diseases. The Notch pathway could represent a new therapeutic target for the treatment of cardiovascular diseases.

Loading

Article metrics loading...

/content/journals/10.5339/gcsp.2013.44
2014-01-01
2019-08-20
Loading full text...

Full text loading...

/deliver/fulltext/gcsp/2013/4/gcsp.2013.44.html?itemId=/content/journals/10.5339/gcsp.2013.44&mimeType=html&fmt=ahah

References

  1. [1]. Gersh   BJ., , Sliwa   K., , Mayosi   BM., , Yusuf   S. . Novel therapeutic concepts: the epidemic of cardiovascular disease in the developing world: global implications. . Eur Heart J . 2010; ;31: : 642– 648 .
    [Google Scholar]
  2. [2]. Weber   C., , Noels   H. . Atherosclerosis: current pathogenesis and therapeutic options. . Nat Med . 2011; ;17: : 1410– 1422 .
    [Google Scholar]
  3. [3]. Artavanis-Tsakonas   S., , Muskavitch   MA. . Notch: the past, the present, and the future. . Curr Top Dev Biol . 2010; ;92: : 1– 29 .
    [Google Scholar]
  4. [4]. Hofmann   JJ., , Iruela-Arispe   ML. . Notch signaling in blood vessels: who is talking to whom about what?.   Circ Res . 2007; ;100: : 1556– 1568 .
    [Google Scholar]
  5. [5]. de la Pompa   JL., , Epstein   JA. . Coordinating tissue interactions: Notch signaling in cardiac development and disease. . Dev Cell . 2012; ;22: : 244– 254 .
    [Google Scholar]
  6. [6]. Quillard   T., , Charreau   B. . Impact of notch signaling on inflammatory responses in cardiovascular disorders. . Int J Mol Sci . 2013; ;14: : 6863– 6888 .
    [Google Scholar]
  7. [7]. Rizzo   P., , Miele   L., , Ferrari   R. . The Notch pathway: a crossroad between the life and death of the endothelium. . Eur Heart J . 2012; .
    [Google Scholar]
  8. [8]. Wiese   C., , Heisig   J., , Gessler   M. . Hey bHLH factors in cardiovascular development. . Pediatr Cardiol . 2010; ;31: : 363– 370 .
    [Google Scholar]
  9. [9]. Espinoza   I., , Miele   L. . Notch inhibitors for cancer treatment. . Pharmacol Ther . 2013; ;139: 2 : 95– 110 .
    [Google Scholar]
  10. [10]. Rizzo   P., , Osipo   C., , Pannuti   A., , Golde   T., , Osborne   B., , Miele   L. . Targeting Notch signaling cross-talk with estrogen receptor and ErbB-2 in breast cancer. . Adv Enzyme Regul . 2009; ;49: : 134– 141 .
    [Google Scholar]
  11. [11]. Gu   JW., , Rizzo   P., , Pannuti   A., , Golde   T., , Osborne   B., , Miele   L. . Notch signals in the endothelium and cancer “stem-like” cells: opportunities for cancer therapy. . Vasc Cell . 2012; ;4: : 7 .
    [Google Scholar]
  12. [12]. Quillard   T., , Coupel   S., , Coulon   F., , Fitau   J., , Chatelais   M., , Cuturi   MC., , Chiffoleau   E., , Charreau   B. . Impaired Notch4 activity elicits endothelial cell activation and apoptosis: implication for transplant arteriosclerosis. . Arterioscler Thromb Vasc Biol . 2008; ;28: : 2258– 2265 .
    [Google Scholar]
  13. [13]. Agnoletti   L., , Curello   S., , Bachetti   T., , Malacarne   F., , Gaia   G., , Comini   L., , Volterrani   M., , Bonetti   P., , Parrinello   G., , Cadei   M., , Grigolato   PG., , Ferrari   R. . Serum from patients with severe heart failure downregulates eNOS and is proapoptotic: role of tumor necrosis factor-alpha. . Circulation . 1999; ;100: : 1983– 1991 .
    [Google Scholar]
  14. [14]. Iiyama   K., , Hajra   L., , Iiyama   M., , Li   H., , DiChiara   M., , Medoff   BD., , Cybulsky   MI. . Patterns of vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 expression in rabbit and mouse atherosclerotic lesions and at sites predisposed to lesion formation. . Circ Res . 1999; ;85: : 199– 207 .
    [Google Scholar]
  15. [15]. Walshe   TE., , Connell   P., , Cryan   L., , Ferguson   G., , Gardiner   T., , Morrow   D., , Redmond   EM., , O'Brien   C., , Cahill   PA. . Microvascular retinal endothelial and pericyte cell apoptosis in vitro: role of Hedgehog and Notch signaling. . Invest Ophthalmol Vis Sci . 2011; ;52: 7 : 4472– 4483 .
    [Google Scholar]
  16. [16]. Noseda   M., , Chang   L., , McLean   G., , Grim   JE., , Clurman   BE., , Smith   LL., , Karsan   A. . Notch activation induces endothelial cell cycle arrest and participates in contact inhibition: role of p21Cip1 repression. . Mol Cell Biol . 2004; ;24: : 8813– 8822 .
    [Google Scholar]
  17. [17]. Kwon   SM., , Eguchi   M., , Wada   M., , Iwami   Y., , Hozumi   K., , Iwaguro   H., , Masuda   H., , Kawamoto   A., , Asahara   T. . Specific Jagged-1 signal from bone marrow microenvironment is required for endothelial progenitor cell development for neovascularization. . Circulation . 2008; ;118: : 157– 165 .
    [Google Scholar]
  18. [18]. Fung   E., , Tang   SM., , Canner   JP., , Morishige   K., , Arboleda-Velasquez   JF., , Cardoso   AA., , Carlesso   N., , Aster   JC., , Aikawa   M. . Delta-like 4 induces notch signaling in macrophages: implications for inflammation. . Circulation . 2007; ;115: : 2948– 2956 .
    [Google Scholar]
  19. [19]. Aoyama   T., , Takeshita   K., , Kikuchi   R., , Yamamoto   K., , Cheng   XW., , Liao   JK., , Murohara   T. . gamma-Secretase inhibitor reduces diet-induced atherosclerosis in apolipoprotein E-deficient mice. . Biochem Biophys Res Commun . 2009; ;383: : 216– 221 .
    [Google Scholar]
  20. [20]. Fukuda   D., , Aikawa   E., , Swirski   FK., , Novobrantseva   TI., , Kotelianski   V., , Gorgun   CZ., , Chudnovskiy   A., , Yamazaki   H., , Croce   K., , Weissleder   R., , Aster   JC., , Hotamisligil   GS., , Yagita   H., , Aikawa   M. . Notch ligand Delta-like 4 blockade attenuates atherosclerosis and metabolic disorders. . Proc Natl Acad Sci U S A . 2012; ;109: 27 : E1868– E1877 .
    [Google Scholar]
  21. [21]. Rudijanto   A. . The role of vascular smooth muscle cells on the pathogenesis of atherosclerosis. . Acta Med Indones . 2007; ;39: : 86– 93 .
    [Google Scholar]
  22. [22]. Edlin   RS., , Tsai   S., , Yamanouchi   D., , Wang   C., , Liu   B., , Kent   KC. . Characterization of primary and restenotic atherosclerotic plaque from the superficial femoral artery: Potential role of Smad3 in regulation of SMC proliferation. . J Vasc Surg . 2009; ;49: : 1289– 1295 .
    [Google Scholar]
  23. [23]. Delbosc   S., , Glorian   M., , Le Port   AS., , Bereziat   G., , Andreani   M., , Limon   I. . The benefit of docosahexanoic acid on the migration of vascular smooth muscle cells is partially dependent on Notch regulation of MMP-2/-9. . Am J Pathol . 2008; ;172: : 1430– 1440 .
    [Google Scholar]
  24. [24]. Luxan   G., , Casanova   JC., , Martinez-Poveda   B., , Prados   B., , D'Amato   G., , MacGrogan   D., , Gonzalez-Rajal   A., , Dobarro   D., , Torroja   C., , Martinez   F., , Izquierdo-García   JL., , Fernández-Friera   L., , Sabater-Molina   M., , Kong   YY., , Pizarro   G., , Ibañez   B., , Medrano   C., , García-Pavía   P., , Gimeno   JR., , Monserrat   L., , Jiménez-Borreguero   LJ., , de la Pompa   JL. . Mutations in the NOTCH pathway regulator MIB1 cause left ventricular noncompaction cardiomyopathy. . Nat Med . 2013; ;19: : 193– 201 .
    [Google Scholar]
  25. [25]. Chen   H., , Zhang   W., , Sun   X., , Yoshimoto   M., , Chen   Z., , Zhu   W., , Liu   J., , Shen   Y., , Yong   W., , Li   D., , Zhang   J., , Lin   Y., , Li   B., , VanDusen   NJ., , Snider   P., , Schwartz   RJ., , Conway   SJ., , Field   LJ., , Yoder   MC., , Firulli   AB., , Carlesso   N., , Towbin   JA., , Shou   W. . Fkbp1a controls ventricular myocardium trabeculation and compaction by regulating endocardial Notch1 activity. . Development . 2013; ;140: : 1946– 1957 .
    [Google Scholar]
  26. [26]. High   FA., , Epstein   JA. . The multifaceted role of Notch in cardiac development and disease. . Nat Rev Genet . 2008; ;9: : 49– 61 .
    [Google Scholar]
  27. [27]. Urbanek   K., , Cabral-da-Silva   MC., , Ide-Iwata   N., , Maestroni   S., , Delucchi   F., , Zheng   H., , Ferreira-Martins   J., , Ogórek   B., , D'Amario   D., , Bauer   M., , Zerbini   G., , Rota   M., , Hosoda   T., , Liao   R., , Anversa   P., , Kajstura   J., , Leri   A. . Inhibition of notch1-dependent cardiomyogenesis leads to a dilated myopathy in the neonatal heart. . Circ Res . 2010; ;107: : 429– 441 .
    [Google Scholar]
  28. [28]. Collesi   C., , Zentilin   L., , Sinagra   G., , Giacca   M. . Notch1 signaling stimulates proliferation of immature cardiomyocytes. . J Cell Biol . 2008; ;183: : 117– 128 .
    [Google Scholar]
  29. [29]. Rentschler   S., , Yen   AH., , Lu   J., , Petrenko   NB., , Lu   MM., , Manderfield   LJ., , Patel   VV., , Fishman   GI., , Epstein   JA. . Myocardial Notch signaling reprograms cardiomyocytes to a conduction-like phenotype. . Circulation . 2012; ;126: : 1058– 1066 .
    [Google Scholar]
  30. [30]. Gude   NA., , Emmanuel   G., , Wu   W., , Cottage   CT., , Fischer   K., , Quijada   P., , Muraski   JA., , Alvarez   R., , Rubio   M., , Schaefer   E., , Sussman   MA. . Activation of Notch-mediated protective signaling in the myocardium. . Circ Res . 2008; ;102: : 1025– 1035 .
    [Google Scholar]
  31. [31]. Campa   VM., , Gutierrez-Lanza   R., , Cerignoli   F., , Diaz-Trelles   R., , Nelson   B., , Tsuji   T., , Barcova   M., , Jiang   W., , Mercola   M. . Notch activates cell cycle reentry and progression in quiescent cardiomyocytes. . J Cell Biol . 2008; ;183: : 129– 141 .
    [Google Scholar]
  32. [32]. Oie   E., , Sandberg   WJ., , Ahmed   MS., , Yndestad   A., , Laerum   OD., , Attramadal   H., , Aukrust   P., , Eiken   HG. . Activation of Notch signaling in cardiomyocytes during post-infarction remodeling. . Scand Cardiovasc J . 2010; ;44: : 359– 366 .
    [Google Scholar]
  33. [33]. Kratsios   P., , Catela   C., , Salimova   E., , Huth   M., , Berno   V., , Rosenthal   N., , Mourkioti   F. . Distinct roles for cell-autonomous Notch signaling in cardiomyocytes of the embryonic and adult heart. . Circ Res . 2010; ;106: : 559– 572 .
    [Google Scholar]
  34. [34]. Nemir   M., , Metrich   M., , Plaisance   I., , Lepore   M., , Cruchet   S., , Berthonneche   C., , Sarre   A., , Radtke   F., , Pedrazzini   T. . The Notch pathway controls fibrotic and regenerative repair in the adult heart. . Eur Heart J . 2012; ;   [Epub ahead of print] .
    [Google Scholar]
  35. [35]. Boni   A., , Urbanek   K., , Nascimbene   A., , Hosoda   T., , Zheng   H., , Delucchi   F., , Amano   K., , Gonzalez   A., , Vitale   S., , Ojaimi   C., , Rizzi   R., , Bolli   R., , Yutzey   KE., , Rota   M., , Kajstura   J., , Anversa   P., , Leri   A. . Notch1 regulates the fate of cardiac progenitor cells. . Proc Natl Acad Sci U S A . 2008; ;105: : 15529– 15534 .
    [Google Scholar]
  36. [36]. Zeglinski   M., , Ludke   A., , Jassal   DS., , Singal   PK. . Trastuzumab-induced cardiac dysfunction: A ‘dual-hit’. . Exp Clin Cardiol . 2011; ;16: : 70– 74 .
    [Google Scholar]
  37. [37]. Arumugam   TV., , Chan   SL., , Jo   DG., , Yilmaz   G., , Tang   SC., , Cheng   A., , Gleichmann   M., , Okun   E., , Dixit   VD., , Chigurupati   S., , Mughal   MR., , Ouyang   X., , Miele   L., , Magnus   T., , Poosala   S., , Granger   DN., , Mattson   MP. . Gamma secretase-mediated Notch signaling worsens brain damage and functional outcome in ischemic stroke. . Nat Med . 2006; ;12: : 621– 623 .
    [Google Scholar]
  38. [38]. Bria   E., , Cuppone   F., , Milella   M., , Verma   S., , Carlini   P., , Nistico   C., , Vaccaro   V., , Rossi   A., , Tonini   G., , Cognetti   F., , Terzoli   E. . Trastuzumab cardiotoxicity: biological hypotheses and clinical open issues. . Expert Opin Biol Ther . 2008; ;8: : 1963– 1971 .
    [Google Scholar]
  39. [39]. Sengupta   PP., , Northfelt   DW., , Gentile   F., , Zamorano   JL., , Khandheria   BK. . Trastuzumab-induced cardiotoxicity: heart failure at the crossroads. . Mayo Clin Proc . 2008; ;83: : 197– 203 .
    [Google Scholar]
  40. [40]. Osipo   C., , Patel   P., , Rizzo   P., , Clementz   AG., , Hao   L., , Golde   TE., , Miele   L. . ErbB-2 inhibition activates Notch-1 and sensitizes breast cancer cells to a gamma-secretase inhibitor. . Oncogene . 2008; ;27: : 5019– 5032 .
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.5339/gcsp.2013.44
Loading
/content/journals/10.5339/gcsp.2013.44
Loading

Data & Media loading...

Supplementary File 1

  • Article Type: Review Article
Keyword(s): apoptosis , atherosclerosis , cardiomyocytes , cardiotoxicity , endothelial cells and heart failure
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error